Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I've tried to get ahold of investor relations numerous times today to inquire about some of the things that were left out of the AI conference. I've yet to get a response from them. Come on Advaxis, you can do better then this!
Uhh, been invested here long enough to realize the missed time lines scenario with regard to goals, hell just look at PETX for example. They were supposed to be on the market over a year ago. Then there's the Asian partners that never materialized.
I can totally understand why folks are dissatisfied with the progress. The dissatisfaction is managements problem, not shareholders, JMO.
I think the share price is a part of it but misleading timelines and a graveyard of failed partnerships are another contributing factor.
Maybe it's time for a leader who is more transparent and less self serving.
As quiet As the company is being on this matter, it does make one wonder.
They could just as easily put out PRs regarding this stuff and saved a lot of money Ignatius. I wasn't impressed at all. Still waiting for news I think we have coming.
No, I just dot see the purpose of having one until you have something great to say. I don't believe our dealings with Astra are over, sometimes what one doesn't say is as important as what they do say.
Yeah, kinda stupid to have an analyst investor day to highlight all your failures!
The fact that they are doing the same with PSA should tell you that Astra could very well be in the game still for AXAL in H&N and end stage cervical. It could very well indicate that someone interested in buying the company wants to see how many different ways these constructs can be exploited to their benefit.
I don't know that anything I saw says they are out, the company is being very quiet on this topic.
I do still think there is something going on with that, maybe why the EU submission timeline has changed?
I didn't hear anything that gave me a warm and fuzzy feeling unless there is a deal with Astra that keeps them from talking about it.
I feel like I call it like I see it and with that said I really wish there would have been no AI conference yesterday. It was a total waste of time watching it.
What I came away with was management backing off on timelines and not casting any light on what happened to Astra. The market dislikes uncertainty.
I have to say a change might be welcomed.
True enough!
It's actually a late stage bio!
Nah, Hot is the ticket, quicker and more efficient.
HFT racketeering that is never ending.
Got a call back from SEC after filing a written complaint online. All the guy would say who called me back would say is they are aware of the situation and are monitoring it at this point.
Yep, it's the only thing that makes sense.
Yeah, that would blindside everyone!
I'm definitely interested in the updates.
It might take eight months of GREEN days to get us to the point an offer could be made, ha ha!
One MEGA-MASSIVE deal with Astra to give this company wings so that it might fly to buyout levels!
So we've shown the EU we have the manufacturing facility and it's been given a thumbs up. All we need now is to show them we have a distribution network in place and we are GOLDEN! One distribution network coming up along with a deal for AXAL in end stage metastatic cervical cancer and H&N!
Can I get in on that bet as well? I'll take Astra as well but would be more then happy to drink a beer either way.
I agree, all at least good stuff and maybe great stuff. I'm sure we won't walk away disappointed!
I'm expecting big news Monday! Am I going to rant,rave and curl up in the fetal position if it doesn't materialize? Nope, if not Monday, it'll happen soon enough! I'll wait!
Yeah, I like the play on words there.
Hey, don't laugh but in 2008 I had a dream I was standing in Times Square in front of the big NASDAQ Jumbotron with their ticker symbol on it in huge letters. To my left all up and down the side street neon signs were flashing at me, "ADVAXIS CURES CANCER."
Here I am today with more confidence that will come to pass then ever.
Management needs to light short interest up really good just once and the BS will stop, JMO.
We know AXAL works and works very well with an extremely low side effect profile. AXAL has been granted orphan designation for these indications which comes with 7 years of exclusivity( more money for a longer period of time). If AXAL for those indications was still available, we wouldn't see BMY partnering up for dual. They've obviously seen results that AXAL is garnering and want a piece of the pie in whatever form ADXS is willing to serve it up.
All of this sky is falling talk is just silly, no way you wouldn't be able to command some big dollars for an orphan product like AXAL in These indications.
I think we close in the GREEN today!!
Any bets on short interest after the close?
I'll say 7.25 million left.
I'm still thinking Monday, ha ha, shorts are trying every game in the book trying to get out of the way. It's obvious if you watch the stock trade at all. The huge spike in volume Tuesday with the resulting SP increase correlates with news monday per sec rules if a deal was indeed signed Tuesday.
Absolutely no doubt in my mind that Astra has already stepped up and grabbed AXAL for H&N and end stage cervical. That's why BMY has signed on for DUAL. Absolutely no doubt!
I think that would make sense, After all we were running trials together with them trying to sell our wares and like I said if Astra didn't have these already locked up, BMY would have jumped at the chance to partner on these two indications both of which have orphan status.
No way we're not selling AXAL for those two indications. Astra and Advaxis have both put time and money into it, plus I think we have orphan for those if memory serves me well.
If that were true we'd be using Dual in the P3 currently running in locally advanced cervical cancer IMO.
They did the same thing with the Amgen deal, sold MINE and pulled out HOT to resell or keep.
DUAL is Advaxis's way of creating a win/win opportunity for our company. Double your interest, double your fun. They should put the double mint twins in the presentation.